Jibiao Wu

1.2k total citations · 1 hit paper
25 papers, 745 citations indexed

About

Jibiao Wu is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Jibiao Wu has authored 25 papers receiving a total of 745 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Cancer Research and 6 papers in Immunology. Recurrent topics in Jibiao Wu's work include Cancer-related molecular mechanisms research (4 papers), Cancer, Lipids, and Metabolism (3 papers) and Immune Cell Function and Interaction (3 papers). Jibiao Wu is often cited by papers focused on Cancer-related molecular mechanisms research (4 papers), Cancer, Lipids, and Metabolism (3 papers) and Immune Cell Function and Interaction (3 papers). Jibiao Wu collaborates with scholars based in China, Macao and Switzerland. Jibiao Wu's co-authors include Wenjie Zhao, Jinhua Liu, Zichao Chen, Zhen Zhang, Yaqun Li, Changgang Sun, Huayao Li, Qihui Sun, Jianhua Zhen and Xiaohong Li and has published in prestigious journals such as Frontiers in Immunology, Critical Reviews in Food Science and Nutrition and BioMed Research International.

In The Last Decade

Jibiao Wu

25 papers receiving 738 citations

Hit Papers

PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy 2021 2026 2022 2024 2021 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy
    2021 275 citations Jinhua Liu, Zichao Chen et al. Frontiers in Pharmacology profile →

Peers

Jibiao Wu
Shunqin Long China
Xiongwei Huo China
Xiaoqun Ye China
Jo-Ting Tsai Taiwan
Guowang Yang China
Zan Fu China
Zhao Wu China
Ga Bin Park South Korea
Jinsun Lee South Korea
Shunqin Long China
Jibiao Wu
Citations per year, relative to Jibiao Wu Jibiao Wu (= 1×) peers Shunqin Long

Countries citing papers authored by Jibiao Wu

Since Specialization
Citations

This map shows the geographic impact of Jibiao Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jibiao Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jibiao Wu more than expected).

Fields of papers citing papers by Jibiao Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jibiao Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jibiao Wu. The network helps show where Jibiao Wu may publish in the future.

Co-authorship network of co-authors of Jibiao Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Jibiao Wu. A scholar is included among the top collaborators of Jibiao Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jibiao Wu. Jibiao Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Jie, et al.. (2024). Vitreoretinal Traction Syndrome, Nitrituria and Human Epidermal Growth Factor Receptor Negative Might Occur in the Aromatase-Inhibitor Anastrozole Treatment. International Journal of Clinical Practice. 2024. 1–9. 10 indexed citations
2.
Cui, Xinhai, Yuanlong Hu, Zhiyuan Zhang, et al.. (2024). Dietary inflammation and vascular calcification: a comprehensive review of the associations, underlying mechanisms, and prevention strategies. Critical Reviews in Food Science and Nutrition. 65(27). 5302–5323. 2 indexed citations
3.
4.
Wang, Jia, Wen‐Feng Zhang, Cun Liu, et al.. (2024). Reprogramming of Lipid Metabolism Mediates Crosstalk, Remodeling, and Intervention of Microenvironment Components in Breast Cancer. International Journal of Biological Sciences. 20(5). 1884–1904. 19 indexed citations
5.
6.
Zhang, Lei, Yuan Li, Wenqing Yang, et al.. (2023). Protocatechuic aldehyde increases pericyte coverage and mitigates pericyte damage to enhance the atherosclerotic plaque stability. Biomedicine & Pharmacotherapy. 168. 115742–115742. 4 indexed citations
7.
Xing, Mengzhen, Yuning Ma, Xiaocen Wei, et al.. (2023). Preparation and Evaluation of Auxiliary Permeable Microneedle Patch Composed of Polyvinyl Alcohol and Eudragit NM30D Aqueous Dispersion. Pharmaceutics. 15(7). 2007–2007. 2 indexed citations
8.
Wu, Wei, Weiwei Tao, Lina Liu, et al.. (2023). Recent advances in regulating lipid metabolism to prevent coronary heart disease. Chemistry and Physics of Lipids. 255. 105325–105325. 6 indexed citations
9.
Yang, Shu, Xiaomin Wang, Lin Hou, et al.. (2023). ncRNA-mediated ceRNA regulatory network: Transcriptomic insights into breast cancer progression and treatment strategies. Biomedicine & Pharmacotherapy. 162. 114698–114698. 43 indexed citations
10.
Li, Xiaohong, et al.. (2022). Andrographolide, a natural anti-inflammatory agent: An Update. Frontiers in Pharmacology. 13. 920435–920435. 74 indexed citations
11.
Liu, Cun, et al.. (2022). Tumor accomplice: T cell exhaustion induced by chronic inflammation. Frontiers in Immunology. 13. 979116–979116. 38 indexed citations
12.
Zhang, Junli, et al.. (2022). Anticancer effects and mechanisms of astragaloside‑IV (Review). Oncology Reports. 49(1). 26 indexed citations
13.
Liu, Qi, et al.. (2022). Targeting hypoxia-inducible factor-1alpha: A new strategy for triple-negative breast cancer therapy. Biomedicine & Pharmacotherapy. 156. 113861–113861. 54 indexed citations
14.
Liu, Jinhua, Zichao Chen, Yaqun Li, et al.. (2021). PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy. Frontiers in Pharmacology. 12. 731798–731798. 275 indexed citations breakdown →
15.
Zhang, Xiaoming, Haiyan Zhang, Jie Li, et al.. (2021). 6-lncRNA Assessment Model for Monitoring and Prognosis of HER2-Positive Breast Cancer: Based on Transcriptome Data. Pathology & Oncology Research. 27. 609083–609083. 6 indexed citations
16.
Wang, Xue, Chundi Gao, Fubin Feng, et al.. (2020). Construction and Analysis of Competing Endogenous RNA Networks for Breast Cancer Based on TCGA Dataset. BioMed Research International. 2020(1). 4078596–4078596. 14 indexed citations
17.
Ma, Xiaoran, Jibiao Wu, Cun Liu, et al.. (2020). Deciphering of Key Pharmacological Pathways of Poria Cocos Intervention in Breast Cancer Based on Integrated Pharmacological Method. Evidence-based Complementary and Alternative Medicine. 2020(1). 4931531–4931531. 8 indexed citations
18.
Pei, Ke, Ting Gui, Chao Li, et al.. (2020). Recent Progress on Lipid Intake and Chronic Kidney Disease. BioMed Research International. 2020(1). 3680397–3680397. 23 indexed citations
19.
Yang, Ying, Ke Pei, Qian Zhang, et al.. (2020). Salvianolic acid B ameliorates atherosclerosis via inhibiting YAP/TAZ/JNK signaling pathway in endothelial cells and pericytes. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1865(10). 158779–158779. 50 indexed citations
20.
Qiu, Bo, et al.. (2014). [In vitro anti-tumor effect of human dendritic cells vaccine induced by astragalus polysacharin: an experimental study].. PubMed. 34(9). 1103–7. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shunqin Long Breakdown of academic impact, for papers by Xiongwei Huo Breakdown of academic impact, for papers by Xiaoqun Ye Breakdown of academic impact, for papers by Jo-Ting Tsai Breakdown of academic impact, for papers by Guowang Yang Breakdown of academic impact, for papers by Zan Fu Breakdown of academic impact, for papers by Zhao Wu Breakdown of academic impact, for papers by Ga Bin Park Breakdown of academic impact, for papers by Jinsun Lee
Rankless by CCL
2026